BRANDT KEVIN D (VP & Chief Commercial Officer) received a stock award from XTANT MEDICAL HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/17/2023ACC: 0001235802-23-000095
Officer· VP & Chief Commercial Officer
Since Jul 2018
+211.20K
Net shares
Net buyer
$58.9K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
261.08K acquired · 49.88K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+120.50K
Price / share
—
Trade value
—
% of position
17.1%
8/15/2023
703.57K→824.07K
Common Stock
Direct
Shares
−49.88K
Price / share
$1.18
Trade value
$58.86K
% of position
6.1%
8/15/2023
824.07K→774.19K
Total
Net shares
+70.62K
Net value
-$58.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/15/2023 | A · Award | +120.50K | — | — | 17.1% | 703.57K | 824.07K |
| Common Stock Direct | 8/15/2023 | F · Tax Withholding | −49.88K | $1.18 | $58.86K | 6.1% | 824.07K | 774.19K |
| Total | +70.62K | -$58.86K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
140.58K shares
Shares
+140.58K
Strike price
1.2
Held after
140.58K
Exercisable
—
8/15/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock140.58K shares | 8/15/2023 | A · Award | +140.58K | 1.2 | — | 140.58K |